Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bueno Muiño

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 21, 2008
Successful rectal cancer local recurrence radiofrequency ablationC Bueno Muiño, J A García-Sáenz, E Santos Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2007
Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinomaC Bueno Muiño, J Puente Vázquez, J Sastre Valera, et al.
ESMO Open|January 18, 2025
HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancersF Lynce, O Martínez-Sáez, B Walbaum, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 14, 2019
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experienceS Pérez Ramírez, M Del Monte-Millán, S López-Tarruella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerG Villacampa, N M Tung, S Pernas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 21, 2008
Successful rectal cancer local recurrence radiofrequency ablationC Bueno Muiño, J A García-Sáenz, E Santos Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2007
Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinomaC Bueno Muiño, J Puente Vázquez, J Sastre Valera, et al.
ESMO Open|January 18, 2025
HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancersF Lynce, O Martínez-Sáez, B Walbaum, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 14, 2019
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experienceS Pérez Ramírez, M Del Monte-Millán, S López-Tarruella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerG Villacampa, N M Tung, S Pernas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Pageof 1